Advanced Enzyme

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE837H01020
  • NSEID: ADVENZYMES
  • BSEID: 540025
INR
291.30
-5.05 (-1.7%)
BSENSE

Nov 20

BSE+NSE Vol: 1.95 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'26
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Net Sales
214.51
191.71
203.37
171.95
184.53
185.91
167.18
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
214.51
191.71
203.37
171.95
184.53
185.91
167.18
Raw Material Cost
59.09
54.50
55.96
45.64
48.74
43.97
45.94
Purchase of Finished goods
0.01
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-2.68
-4.81
0.97
-4.23
-4.18
6.08
0.15
Employee Cost
40.45
44.55
41.94
41.26
39.37
39.71
36.84
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.01
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
45.52
44.58
41.27
39.93
40.53
39.72
38.64
Total Expenditure (Excl Depreciation)
142.39
138.82
140.14
122.60
124.47
129.48
121.57
Operating Profit (PBDIT) excl Other Income
72.12
52.89
63.23
49.35
60.06
56.43
45.61
Other Income
8.72
11.10
7.23
8.47
10.28
8.85
8.75
Operating Profit (PBDIT)
80.84
63.99
70.46
57.82
70.34
65.28
54.36
Interest
1.18
0.58
0.57
0.57
0.72
0.76
0.81
Exceptional Items
0.00
0.00
0.11
11.25
0.00
0.00
0.00
Gross Profit (PBDT)
79.66
63.41
70.00
68.50
69.62
64.52
53.55
Depreciation
10.90
9.88
10.19
10.21
10.08
9.62
10.08
Profit Before Tax
68.76
53.53
59.80
58.29
59.54
54.90
43.46
Tax
17.59
14.94
14.55
15.11
14.81
14.46
16.73
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
51.17
38.59
45.25
43.18
44.73
40.44
26.73
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
51.17
38.59
45.25
43.18
44.73
40.44
26.73
Share in Profit of Associates
-0.02
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
2.85
1.50
2.29
0.68
1.41
0.51
0.25
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
48.31
37.09
42.96
42.50
43.33
39.93
26.48
Equity Capital
22.05
22.40
22.39
22.39
22.38
22.38
22.38
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
4.38
3.31
3.84
3.8
3.87
3.57
2.37
Diluted Earnings per share
4.32
3.31
3.84
3.79
3.87
3.57
2.37
Operating Profit Margin (Excl OI)
33.62%
27.59%
31.09%
28.7%
32.55%
30.35%
27.28%
Gross Profit Margin
37.14%
33.08%
34.42%
39.84%
37.73%
34.7%
32.03%
PAT Margin
23.85%
20.13%
22.25%
25.11%
24.24%
21.75%
15.99%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Sep 2026 is 16.25% vs 26.30% in Sep 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Sep 2026 is 11.49% vs 31.98% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2026 is 20.08% vs 41.58% in Sep 2025

stock-summary

Interest

YoY Growth in quarter ended Sep 2026 is 63.89% vs -22.58% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2026 has improved from Sep 2025

Compare Quarterly Results Of Advanced Enzyme With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
214.51
417.34
-202.83
-48.60%
Other Operating Income
0.00
0.00
0.00
Total Operating income
214.51
417.34
-202.83
-48.60%
Raw Material Cost
59.09
217.80
-158.71
-72.87%
Purchase of Finished goods
0.01
2.30
-2.29
-99.57%
(Increase) / Decrease In Stocks
-2.68
-6.43
3.75
58.32%
Employee Cost
40.45
57.62
-17.17
-29.80%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
45.52
69.21
-23.69
-34.23%
Total Expenditure (Excl Depreciation)
142.39
340.50
-198.11
-58.18%
Operating Profit (PBDIT) excl Other Income
72.12
76.84
-4.72
-6.14%
Other Income
8.72
0.54
8.18
1,514.81%
Operating Profit (PBDIT)
80.84
77.38
3.46
4.47%
Interest
1.18
17.78
-16.60
-93.36%
Exceptional Items
0.00
-4.50
4.50
100.00%
Gross Profit (PBDT)
79.66
55.10
24.56
44.57%
Depreciation
10.90
26.64
-15.74
-59.08%
Profit Before Tax
68.76
28.46
40.30
141.60%
Tax
17.59
0.00
17.59
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
51.17
28.46
22.71
79.80%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
51.17
28.46
22.71
79.80%
Share in Profit of Associates
-0.02
0.00
-0.02
Minority Interest
2.85
0.00
2.85
Other related items
0.00
0.00
0.00
Consolidated Net Profit
48.31
28.46
19.85
69.75%
Equity Capital
22.05
48.16
-26.11
-54.22%
Face Value
2.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
4.38
5.91
-1.53
-25.89%
Diluted Earnings per share
4.32
5.92
-1.60
-27.03%
Operating Profit Margin (Excl OI)
33.62%
18.41%
0.00
15.21%
Gross Profit Margin
37.14%
13.20%
0.00
23.94%
PAT Margin
23.85%
6.82%
0.00
17.03%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 214.51 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 11.89% vs -5.73% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 16.25% vs 26.30% in Sep 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 48.31 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 30.25% vs -13.66% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 11.49% vs 31.98% in Sep 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 72.12 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 36.36% vs -16.35% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 20.08% vs 41.58% in Sep 2025

Quarterly - Interest
Interest 1.18 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 103.45% vs 1.75% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 63.89% vs -22.58% in Sep 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 33.62%
in Sep 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 has improved from Sep 2025